当前位置:首页 - 行情中心 - 小方制药(603207) - 财务分析

小方制药

(603207)

  

流通市值:10.58亿  总市值:43.18亿
流通股本:3919.78万   总股本:1.60亿

小方制药(603207)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.62亿元,每股收益1.28元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益119043.51万元,未分配利润50978.64万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产135133.58万元,负债16090.07万元。

利润表
报告期2024-09-302024-06-302023-12-312023-09-30
营业总收入367,213,945.74261,788,742.56471,871,615.15367,014,216.77
营业总成本179,224,454.99122,116,783.78240,789,017.91174,327,199.42
营业利润189,081,288.34139,243,444.25236,179,914.5196,269,608.52
利润总额188,771,211.23138,933,390.15237,169,952.06197,259,646.08
净利润161,669,487.31118,815,930.83203,627,027.66168,527,959.91
其他综合收益----
综合收益总额161,669,487.31118,815,930.83203,627,027.66168,527,959.91
资产负债表
报告期2024-09-302024-06-302023-12-312022-12-31
流动资产合计998,784,898.4525,406,423.23452,062,918.8327,867,061.92
非流动资产合计352,550,863.22316,459,358.57260,588,027.32135,431,908.7
资产总计1,351,335,761.62841,865,781.8712,650,946.12463,298,970.62
流动负债合计160,719,636.58142,404,115.16132,176,250.3989,962,703.19
非流动负债合计181,071.35295,488.01520,488.09973,841.5
负债合计160,900,707.93142,699,603.17132,696,738.4890,936,544.69
归属于母公司股东权益合计1,190,435,053.69699,166,178.63579,954,207.64372,362,425.93
股东权益合计1,190,435,053.69699,166,178.63579,954,207.64372,362,425.93
负债和股东权益合计1,351,335,761.62841,865,781.8712,650,946.12463,298,970.62
现金流量表
报告期2024-09-302024-06-302023-12-312023-09-30
经营活动现金流入小计408,561,286.57260,026,082.16535,835,098.26408,507,198.1
经营活动现金流出小计240,892,322.39158,221,126.25335,576,972.75255,672,138.45
经营活动产生的现金流量净额167,668,964.18101,804,955.91200,258,125.51152,835,059.65
投资活动现金流入小计5,989,655.75,989,655.7157,546,602.833,349,205.82
投资活动现金流出小计367,508,531.1440,770,674.51131,151,411.07107,637,804.33
投资活动产生的现金流量净额-361,518,875.44-34,781,018.8126,395,191.76-104,288,598.51
筹资活动现金流入小计473,683,876.81-1,975,4391,975,439
筹资活动现金流出小计10,356,021.863,476,452.354,754,988.814,019,695.47
筹资活动产生的现金流量净额463,327,854.95-3,476,452.35-2,779,549.81-2,044,256.47
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额269,477,943.6963,547,484.75223,873,767.4646,502,204.67
期末现金及现金等价物余额552,013,365.43346,082,906.49282,535,421.74105,163,858.95
TOP↑